Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model.

[1]  Comparative effects of griseofulvin on onychomycosis and on psoriasis unguium. , 1960, Archives of dermatology.

[2]  H. Maibach,et al.  Short-term treatment of onychomycosis with griseofulvin. , 1960, Archives of dermatology.

[3]  P. Quintavalle.  Onychomycosis treated with ultrafine griseofulvin. , 1966, Journal of the American Podiatry Association.

[4]  An effective oral antifungal for chronic infections in the aged. , 1966, Journal of the American Podiatry Association.

[5]  M. Walshe,et al.  FUNGI IN NAILS. , 1966, The British journal of dermatology.

[6]  R. Davies,et al.  Mycological and Clinical Evaluation of Griseofulvin for Chronic Onychomycosis , 1967, British medical journal.

[7]  J. Hanifin,et al.  Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin. , 1980, Reviews of infectious diseases.

[8]  R. Negroni,et al.  The activity of ketoconazole in the treatment of onychomycosis. , 1980, Reviews of infectious diseases.

[9]  V. Schuermans,et al.  An evaluation of two years of clinical experience with ketoconazole. , 1980, Reviews of infectious diseases.

[10]  S. Nuijten,et al.  Further Experiences with Ketoconazole in the Treatment of Onychomycosis , 1981, Mykosen.

[11]  J. Hanifin,et al.  Ketoconazole in griseofulvin-resistant dermatophytosis. , 1982, Journal of the American Academy of Dermatology.

[12]  D. Drachman,et al.  A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize. , 1983, Journal of the American Academy of Dermatology.

[13]  M. Johnson,et al.  Prevalence, morbidity, and cost of dermatologic diseases. , 1984, Journal of the American Academy of Dermatology.

[14]  R. Hay,et al.  A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis , 1985, The British journal of dermatology.

[15]  E. Svejgaard.  Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis. , 1985, Acta dermato-venereologica.

[16]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[17]  R. Hay,et al.  Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. , 1987, Reviews of infectious diseases.

[18]  Ketoconazole in the treatment of onychomycosis. , 1987 .

[19]  R. Hay,et al.  An evaluation of itraconazole in the management of onychomycosis , 1988, The British journal of dermatology.

[20]  E. Evans,et al.  Treatment of dermatophyte infection of the finger‐ and toe‐nails with terbinafine (SF 86‐327, Lamisil), an orally active fungicidal agent , 1989, The British journal of dermatology.

[21]  R. C. Summerbell,et al.  Onychomycosis, Tinea Pedis and Tinea Manuum Caused by Non‐Dermatophytic Filamentous Fungi Nicht‐Dermatophyten‐Fadenpilze als Erreger von Onychomykosen, Tinea pedis und Tinea manuum , 1989, Mycoses.

[22]  N. Zaias,et al.  The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine , 1989, Clinical and experimental dermatology.

[23]  E. Svejgaard,et al.  Itraconazole in onychomycosis. Open and double-blind studies. , 1990, Acta dermato-venereologica.

[24]  N. Zaias.  Management of onychomycosis with oral terbinafine. , 1990, Journal of the American Academy of Dermatology.

[25]  V. Velanovich.  Meta-analysis for combining Bayesian probabilities. , 1991, Medical hypotheses.

[26]  Terbinafine and onychomycosis. , 1991 .

[27]  R. Arenas,et al.  Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent , 1991, International journal of dermatology.

[28]  N. Shear,et al.  Terbinafine: an oral and topical antifungal agent. , 1991, Clinics in dermatology.

[29]  M. K. Moawad,et al.  Fungal infection as a cause of skin disease in the Eastern Province of Saudi Arabia: prevailing fungi and pattern of infection , 1991, Mycoses.

[30]  F. Mosteller,et al.  A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.

[31]  Y. Clayton.  Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses , 1992, Clinical and experimental dermatology.

[32]  J. V. van Cutsem,et al.  Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. , 1992, Journal of the American Academy of Dermatology.

[33]  M. Crijns,et al.  A randomized treatment duration‐finding study of terbinafine in onychomycosis , 1992, The British journal of dermatology.

[34]  T. Jones,et al.  Special features of the clinical use of oral terbinafine in the treatment of fungal diseases , 1992, The British journal of dermatology.

[35]  D. Roberts,et al.  Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey , 1992, The British journal of dermatology.

[36]  E. Evans,et al.  Short term treatment of dermatophyte onychomycosis with terbinafine. , 1992, BMJ.

[37]  M. Goodfield.  Short‐duration therapy with terbinafine for dermatophyteonychomycosis: A multicentre trial , 1992, The British journal of dermatology.

[38]  B. Coldiron.  Recalcitrant onychomycosis of the toenails successfully treated with fluconazole. , 1992, Archives of dermatology.

[39]  F. Baudraz-Rosselet,et al.  Treatment of onychomycosis with terbinafine , 1992, The British journal of dermatology.

[40]  K. Kohtamäki,et al.  Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. , 1992, The Journal of antimicrobial chemotherapy.

[41]  G. Nahass,et al.  Onychomycosis: successful treatment with once-weekly fluconazole. , 1993, Dermatology.

[42]  D. Roseeuw,et al.  New approaches to the treatment of onychomycosis. , 1993, Journal of the American Academy of Dermatology.

[43]  R. Savin,et al.  Terbinafine in Onychomycosis—A Mini Study , 1993, International journal of dermatology.

[44]  D K Owens,et al.  Development of outcome-based practice guidelines: a method for structuring problems and synthesizing evidence. , 1993, The Joint Commission journal on quality improvement.

[45]  M. Ollert,et al.  Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole , 1993, Antimicrobial Agents and Chemotherapy.

[46]  G. Midgley,et al.  Mycology of nail disorders. , 1994, Journal of the American Academy of Dermatology.

[47]  T. Einarson,et al.  A multinational pharmacoeconomic analysis of oral therapies for onychomycosis , 1994, The British journal of dermatology.

[48]  M. Halpern,et al.  Modeling the cost-effectiveness of oral therapy for nail fungus , 1995 .

[49]  R. Davis,et al.  Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections. , 1995, PharmacoEconomics.

[50]  P. Nordin,et al.  Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. , 1995, Journal of the American Academy of Dermatology.

[51]  [Effects of fluconazole on onychomycosis in the patients with collagen diseases]. , 1995, Ryumachi. [Rheumatism].

[52]  H. Zaun,et al.  Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. , 1995, Archives of dermatology.

[53]  M. Bräutigam,et al.  Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group. , 1995, Journal of the American Academy of Dermatology.

[54]  R. Arenas,et al.  OPEN RANDOMIZED COMPARISON OE ITRACONAZOLE VERSUS TERBINAEINE IN ONYCHOMYCOSIS , 1995, International journal of dermatology.

[55]  R. Schopf,et al.  Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection , 1995, BMJ.

[56]  B. Elewski,et al.  Clinical pearl: systemic antifungal drugs and drug interactions. , 1995, Journal of the American Academy of Dermatology.

[57]  K. Ahn,et al.  EFFICACY AND TOLERABILITY OF ITRACONAZOLE IN PATIENTS WITH FINGERNAIL ONYCHOMYCOSIS: A 6-WEEK PILOT STUDY , 1995 .

[58]  D. Denning,et al.  Fortnightly Review: Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology) , 1995, BMJ.

[59]  D. Lackland,et al.  An evaluation of the safety and efficacy of fluconazole in the treatment of onychomycosis. , 1995, Southern medical journal.

[60]  H. Zaun,et al.  Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. , 1995, Archives of dermatology.

[61]  J. Peyri,et al.  Prevalence of dermatophyte onychomycosis in Spain: a cross‐sectional study , 1995, The British journal of dermatology.

[62]  S. Arikian,et al.  Rank-order Stability Analysis (ROSA) , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[63]  Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. , 1996 .